Adarx
3 known investors
ADARx is a clinical-stage biopharmaceutical company developing RNA-based medicines using its RNA science expertise and proprietary targeted delivery platforms to silence disease-causing genes. Its pipeline targets chronic conditions including genetic, complement-mediated, cardiovascular, cardiometabolic, central nervous system, and metabolic diseases.
BiotechMedical Devices
Investors · 3
Frequently asked questions
- What does Adarx do?
- ADARx is a clinical-stage biopharmaceutical company developing RNA-based medicines using its RNA science expertise and proprietary targeted delivery platforms to silence disease-causing genes. Its pipeline targets chronic conditions including genetic, complement-mediated, cardiovascular, cardiometabolic, central nervous system, and metabolic diseases.
- Who are Adarx's investors?
- Adarx's investors include OrbiMed, TCG Crossover, Vivo Capital.